H.R. 3160 · 118th Congress

Pharmaceutical Research Transparency Act of 2023

Stage
In committee
Sponsor
Jamie Raskin
Introduced
2023-05-09
Latest action
2023-05-12 · Referred to the Subcommittee on Health.

Action history

  1. 2023-05-12Referred to the Subcommittee on Health.
  2. 2023-05-09Introduced in House
  3. 2023-05-09Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. 2023-05-09Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.